Determinants of underdiagnosis of COPD in national and international surveys

Chest

Volumn 148, Issue 4, 2015, Pages 971-985

  Lamprecht, Bernd ^a,b   Soriano, Joan B ^c   Studnicka, Michael ^d   Kaiser, Bernhard ^b   Vanfleteren, Lowie E ^e,f   Gnatiuc, Louisa ^g   Burney, Peter ^g   Miravitlles, Marc ^h   Garcîa Rio, Francisco ⁱ   Akbari, Kaveh ^a   Ancochea, Julio ^j   Menezes, Ana M ^k   Perez Padilla, Rogelio ^l   De Oca, Maria Montes ^m   Torres Duque, Carlos A ^n,o   Caballero, Andres ^o,p   González Garcîa, Mauricio ⁿ   Buist, Sonia ^q   Menezes, Ana Maria B ^r   Talamo, Carlos ^r   Lopez Varela, Maria Victorina ^r   Muino, Adriana ^r   Valdivia, Gonzalo ^r   Lisboa, Carmem ^r   Jardim, Jose Roberto B ^r   more..

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Centre of Expertise for Chronic Organ Failure   (Netherlands)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^j UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^k FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^l INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^m HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

ⁿ FUNDACIÓN NEUMOLÓGICA COLOMBIANA   (Colombia)

^o Asociacion Colombiana de Neumologia y Cirugia de Torax   (Colombia)

^p Clinica Reina Sofia   (Colombia)

^q OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^r Oregon Health and Science University ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; AGE DISTRIBUTION; AIRWAY OBSTRUCTION; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLOMBIA; CONTROLLED STUDY; DIAGNOSTIC ERROR; EDUCATIONAL STATUS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SPIROMETRY; UNDERDIAGNOSIS; UNITED STATES; AGED; HEALTH; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; VITAL CAPACITY;

ADULT; AGED; DIAGNOSTIC ERRORS; FEMALE; FORCED EXPIRATORY VOLUME; GLOBAL HEALTH; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VITAL CAPACITY;

EID: 84943410734     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-2535     Document Type: Article

References (35)

1. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003; 123 (5): 1684-1692.
2. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and metaanalysis . Eur Respir J. 2006; 28 (3): 523-532.
3. Vestbo J, Hurd SS, Agustî AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187 (4): 347-365.
4. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009; 374 (9691): 721-732.
5. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349 (9064): 1498-1504.
6. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012; 380 (9859): 2163-2196.
7. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013; 369 (5): 448-457.
8. Ford ES, CroftJB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance-United States, 1999-2011. Chest. 2013; 144 (1): 284-305.
9. Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD. 2005; 2 (2): 277-283.
10. Menezes AM, Victora CG, Perez-Padilla R; PLATINO Team. The PLATINO project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol. 2004; 4 : 15.
11. Ancochea J, Badiola C, Duran-Tauleria E, et al. The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-yearolds: protocol summary [in Spanish]. Arch Bronconeumol. 2009; 45 (1): 41-47.
12. Caballero A, Torres-Duque CA, Jaramillo C, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008; 133 (2): 343-349.
13. Buist AS, McBurnie MA, Vollmer WM, et al; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007; 370 (9589): 741-750.
14. Menezes AM, Perez-Padilla R, Jardim JR, et al; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005; 366 (9500): 1875-1881.
15. Miravitlles M, Soriano JB, Garcîa-Rîo F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009; 64 (10): 863-868.
16. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995; 152 (3): 1107-1136.
17. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999; 159 (1): 179-187.
18. Peña VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000; 118 (4): 981-989.
19. Soriano JB, Ancochea J, Miravitlles M, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J. 2010; 36 (4): 758-765.
20. Miravitlles M, de la Roza C, Naberan K, et al. Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care [in Spanish]. Arch Bronconeumol. 2006; 42 (1): 3-8.
21. van Dijk WD, Gupta N, Tan WC, Bourbeau J. Clinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic review. COPD. 2014; 11 (1): 113-120.
22. Hancox RJ, Poulton R, Greene JM, McLachlan CR, Pearce MS, Sears MR. Associations between birth weight, early childhood weight gain and adult lung function. Thorax. 2009; 64 (3): 228-232.
23. Stein CE, Kumaran K, Fall CH, Shaheen SO, Osmond C, Barker DJ. Relation of fetal growth to adult lung function in south India. Thorax. 1997; 52 (10): 895-899.
24. Canoy D, Pekkanen J, Elliott P, et al. Early growth and adult respiratory function in men and women followed from the fetal period to adulthood. Thorax. 2007; 62 (5): 396-402.
25. Misra P, Srivastava R, Krishnan A, Sreenivaas V, Pandav CS. Indoor air pollution-related acute lower respiratory infections and low birthweight: a systematic review. J Trop Pediatr. 2012; 58 (6): 457-466.
26. Shaheen SO, Barker DJ, Holgate ST. Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 1995; 151 (5): 1649-1651.
27. Kulkarni N, Pierse N, Rushton L, Grigg J. Carbon in airway macrophages and lung function in children. N Engl J Med. 2006; 355 (1): 21-30.
28. Burney P, Jithoo A, Kato B, et al; Burden of Obstructive Lung Disease (BOLD) Study. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty-a BOLD analysis. Thorax. 2014; 69 (5): 465-473.
29. Perez-Padilla R, Fernandez R, Lopez Varela MV, et al. Airflow obstruction in never smokers in five Latin American cities: the PLATINO study. Arch Med Res. 2012; 43 (2): 159-165.
30. Castillo D, Guayta R, Giner J, et al; FARMAEPOC group. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Respir Med. 2009; 103 (6): 839-845.
31. Nielsen HM, Rødsgaard PA, Weinreich UM. Chronic obstructive pulmonary disease as comorbidity in patients admitted to a university hospital: a cross-sectional study. Clin Respir J. 2014 ;8(3):274-280.
32. Yamasaki A, Hashimoto K, Hasegawa Y, et al. COPDis frequent in conditions of comorbidity in patients treated with various diseases in a university hospital. Int J Chron Obstruct Pulmon Dis. 2010; 5 : 351-355.
33. Pietinalho A, Kinnula VL, Sovijärvi AR, et al. Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report. Respir Med. 2007; 101 (7): 1419-1425.
34. Tuomisto L, Jarvinen V, Laitinen J, Erhola M, Kaila M, Brander P. Asthma Programme in Finland: the quality of primary care spirometry is good. Prim Care Respir J. 2008; 17 (4): 226-231.
35. Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med. 2004; 350 (26): 2689-2697.